Logo
Registered Members Login:
   
Forgotten Your Details? Click Here To Recover +
Welcome to ShareScene - Talk Shares And Take Stock With Australia's Sharemarket Community - New Here? Click To Register >

766 Pages (Click to Jump) V  < 1 2 3 4 5 6 > »    
 
  
Reply to this topic

BLT, BENITEC BIOPHARMA LIMITED
plastic
post Posted: May 9 2015, 02:07 PM
  Quote Post


Posts: 6,375
Thanks: 212


All these happenings but still nothing happens. What is the turn key event one wonders.

Can't be certain but there is this further happening next week.

QUOTE
WASHINGTON | Thu May 7, 2015 4:37pm EDT





Email


Facebook


Twitter



WASHINGTON (Reuters) - The U.S. Senate will begin debate next week on legislation granting President Barack Obama "fast-track" negotiating authority key to completing a sweeping Pacific trade pact, Senate Majority Leader Mitch McConnell said on Thursday




--------------------
Where are the Americans?
 
plastic
post Posted: May 8 2015, 06:53 PM
  Quote Post


Posts: 6,375
Thanks: 212


And now this. People will remember Millenium as the predecessor of ALNY. Note the BLUE reference too.

The article reinforces the theory that PFE is aligned with ALNY...NOT...BLT. Check out his replacement and where he used to work. Where is BLT's trial being held again?

Seems to me, someone knows where the pastures are greener (at ALNY) and decided to let his successor suck some eggs.

http://www.fiercebiotech.com/story/pfizer-...tm_campaign=rss


QUOTE
José-Carlos Gutiérrez-Ramos, Pfizer's ($PFE) prominent head of BioTherapeutics R&D in Cambridge, MA, is leaving the pharma giant and jumping into the booming biotech world, prompting a promotion inside the multibillion-dollar research group.

There's no word yet just where Gutiérrez-Ramos plans to land, just a brief remark in Pfizer's statement that he "decided to return to the biotech sector in the Cambridge area."

The research exec, though, is extraordinarily well connected, with a long track record in drug development that dates back to a stint at Millennium, where he worked with a group of biotech startup execs like Nick Leschly at bluebird bio ($BLUE) and Agios ($AGIO) CEO David Schenkein. And he's headed back to biotech during boom times for the industry.

Michael Ehlers is stepping into Gutiérrez-Ramos's position in Cambridge. Ehlers has been CSO of Pfizer's neuroscience and pain unit, joining the company in 2010 after working as a Howard Hughes Medical Institute Investigator at Duke.




--------------------
Where are the Americans?
 
plastic
post Posted: May 8 2015, 04:31 AM
  Quote Post


Posts: 6,375
Thanks: 212


Remember the puff piece with salesman sitting in his office in front of the white board with various company names written all over it? One of those names was Bluebird. Take a look at the price of them now. $150 per share with a market cap of $4.5BN!

Now tell me why if they are one of the companies that NEED ddRNAi and BLT permission why they don't just buy BLT for stock.

All birds killed with one stone. BLT gets its US listing. Strategy can be adopted by BLUE. Means to develop the IP is available. Value enhanced. The problem is you'd only get one share for every 200 or whatever.






--------------------
Where are the Americans?

Said 'Thanks' for this post: rubra  
 
plastic
post Posted: May 5 2015, 12:04 AM
  Quote Post


Posts: 6,375
Thanks: 212


Bayer goes with ISIS and their antisense platform despite being branded with ddRNAi by having their name on the BLT patent documentation.

PFE has already shown this to be their strategy.

Who's left for BLT? Go it alone strategy perhaps. If so, good luck.






--------------------
Where are the Americans?
 
Pannobhaso
post Posted: May 4 2015, 12:11 PM
  Quote Post


Posts: 515
Thanks: 340


In Reply To: plastic's post @ May 2 2015, 03:22 PM

QUOTE
Will we have a bloodbath through May for BLT?


I guess today's announcement answers that question. The answer is NO.



--------------------
"It turns out Pannobhaso is right."
Plastic (Alias rubra)
 
plastic
post Posted: May 3 2015, 01:06 PM
  Quote Post


Posts: 6,375
Thanks: 212


There is a interesting little company in NZ called NZ Finance. Total shell. Just had one deal fall over and is about to reveal details for a capital return. They don't say what they will do with the shell.

The aspect to the company I find most interesting is the fact that Enumerate is a shareholder.

Makes me wonder if some biotech entity will be backed into it kicking off the bio bubble. They say all will be revealed next week sometime.



--------------------
Where are the Americans?
 


plastic
post Posted: May 2 2015, 03:22 PM
  Quote Post


Posts: 6,375
Thanks: 212


Have to wonder just what it is we are waiting for. Abe has left the US and still no public disclosure but we get the following indicating IP rights issues are still not resolved. If they're not resolved then there can be no deal made. Will we have a bloodbath through May for BLT?

http://www.japantimes.co.jp/news/2015/05/0...s/#.VURdVXtzXML


QUOTE
WASHINGTON – Ministers from the 12 countries negotiating the vaunted Trans-Pacific Partnership free-trade bloc are expected to meet in the Philippines for three days starting May 26, according to U.S. Undersecretary of State for Economic Growth Catherine Novelli told reporters on Thursday.

The U.S., Japan and other participants aim to reach broad accord at the meeting. It will closely follow a gathering of chief negotiators in Guam, where topics to be hammered out include protection of intellectual property rights.

But analysts say a political settlement at the ministerial meeting will require a breakthrough in bilateral talks between Tokyo and Washington and the enactment of trade promotion authority (TPA), which would give U.S. President Barack Obama “fast track” authority to negotiate trade deals.

A spokesman at the Office of the U.S. Trade Representative told Jiji Press that the meeting of the chief negotiators will be held in Guam on May 15-25, but added that a ministerial meeting has not been set.




--------------------
Where are the Americans?
 
plastic
post Posted: May 2 2015, 01:23 AM
  Quote Post


Posts: 6,375
Thanks: 212


Hope burns eternal but when RA Capital's main man doesn't even acknowledge your programme despite being a shareholder in it then you are in a bit of a quandary.

http://fortune.com/2015/04/30/gilead-acqui...d=yahoo_fortune

QUOTE
With that hefty cash flow, CEO John Martin said he was ready to spend some of that money on significant acquisitions—whether large or small. "We are open to suggestions," he said during Thursday's earnings call in a nod to the rampant speculation on possible targets.

Martin, who was recently named CEO of the year for 2014 by investment research firm Morningstar, added that he'd look to buy treatments for diseases in which the company already specializes. Gilead's hepatitis C drugs Sovaldi and Harvoni, along with its portfolio of HIV therapies, make up the vast majority of its revenues.




--------------------
Where are the Americans?
 
plastic
post Posted: May 1 2015, 05:54 PM
  Quote Post


Posts: 6,375
Thanks: 212


Even the pump jockeys on HC have been told to shut up and maintain radio silence for the next little while.

Something must be up. But could still be a while yet before the wrappers are off. No guarantees that it will be good either. Just look at Uncle Mel's track record. Towers are about to be stormed if you ask me. All final defences to be smashed. Hell. I might even buy some myself. Could do with a significant premium a ' la CST.



--------------------
Where are the Americans?
 
plastic
post Posted: May 1 2015, 05:04 AM
  Quote Post


Posts: 6,375
Thanks: 212


Can you imagine the response if there were something precipitous about to come out of the HCV trials. A FDA intervention perhaps rescinding the trial or a request for more data. It would be a total disaster. I wonder if the movement in the US tonight is some smarty pants getting out ahead of such a thing or just a sell down in the overall malaise.

If a significant premium or any other kind of transaction is to be had it had better happen soon.





--------------------
Where are the Americans?

Said 'Thanks' for this post: rubra  
 
 


766 Pages (Click to Jump) V  < 1 2 3 4 5 6 > » 

Back To Top Of Page
Reply to this topic


You agree through the use of ShareScene.com, that you understand and accept the TERMS OF USE.


TERMS OF USE  -  CONTACT ADMIN  -  ADVERTISING